HMH Plasma Work for COVID-19 in Next Phase
December 21, 2020
![](/-/media/Project/HMH/HMH/CDI/wp-content/uploads/2020/12/NJStandsUpToCOVID13.png)
Treatments using antibodies of pandemic survivors enters new Phase 2 evaluation
Researchers and clinical experts at Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, continue their work on convalescent plasma treatments for COVID-19 patients – now with a new Phase 2 study.